500
Participants
Start Date
June 30, 2003
Primary Completion Date
August 31, 2005
Study Completion Date
August 31, 2006
fluticasone
fluticasone (100 microgram twice daily) treatment
montelukast
Montelukast (5 or 10 mg each night).
Fluticasone plus salmeterol
fluticasone (100 microgram) plus salmeterol (50 microgram) each night
New York Consortium (New York Univ. and Columbia Univ.), New York
New York Medical College, Valhalla
Long Island Jewish Hospital (and North Shore Hospital), New Hyde Park
Thomas Jefferson Hospital, Philadelphia
Duke University School of Medicine, Durham
Emory University, Atlanta
Nemour's Childrens Center, Jacksonville
University of Miami (and University of South Florida in Tampa), Miami
University of Alabama at Birmingham, Birmingham
Ohio State University, Columbus
Indiana University, Indianapolis
University of Minnesota, Minneapolis
Illinois Consortium (Northwestern, Univ. of Chicago, Univ. of Illinois), Chicago
Washington University, St Louis
University of Missouri at Kansas City, Kansas City
Louisiana State University, New Orleans
Baylor College of Medicine, Houston
National Jewish Hospital, Denver
Northern New England Consortium (Univ. of Vermont and other locations), Burlington
Lead Sponsor
Collaborators (1)
GlaxoSmithKline
INDUSTRY
JHSPH Center for Clinical Trials
OTHER